Who founded Transradial Technologies?

Transradial Technologies was founded by Steve Green in 2023.

How much funding has Transradial Technologies raised?

Transradial Technologies has disclosed $350K raised across 1 round.

Where is Transradial Technologies headquartered?

Transradial Technologies is headquartered in Syracuse, US.

Transradial Technologies

Syracuse, US · Founded 2023 · Delaware corporation

Find your way into Transradial Technologies

Paths you didn't know you had: your email and LinkedIn already hold routes to the Transradial Technologies team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Transradial Technologies develops SAPH, an investigational radial closure system designed to support hemostasis and reduce radial artery occlusion during interventional cardiology procedures. The company targets interventional cardiologists and cardiology centers seeking safer, simpler alternatives to traditional radial closure methods.

Hardware Healthtech Medical Devices

Founders & leadership

Transradial Technologies was founded in 2023 by Steve Green.

Steve GreenPresident, Co-Founder & Co-Inventor

Randolph Wayne HubbellExecutive

Ronald CaputoInterventional Cardiologist

Reported raises · per SEC filings

Form D private placements

$350K disclosed across 1 round · 2024

▶$350KraisedNov 2024 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Stephen Michael GreenExecutive Officer, Director
Randolph Wayne HubbellExecutive Officer, Director
Ronald Paul CaputoExecutive Officer, Director

Offering amount: $3M
Amount sold: $350K
Proceeds to insiders: $230K
First sale: Nov 2024
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b, 04.3

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies working in the same space as Transradial Technologies.

Frequently asked questions

What does Transradial Technologies do?: Transradial Technologies develops SAPH, an investigational radial closure system designed to support hemostasis and reduce radial artery occlusion during interventional cardiology procedures. The company targets interventional cardiologists and cardiology centers seeking safer, simpler alternatives to traditional radial closure methods.
Who founded Transradial Technologies?: Transradial Technologies was founded by Steve Green in 2023.
How much funding has Transradial Technologies raised?: Transradial Technologies has disclosed $350K raised across 1 round.
Where is Transradial Technologies headquartered?: Transradial Technologies is headquartered in Syracuse, US.